Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 May;93(5):582–590. doi: 10.1111/j.1349-7006.2002.tb01294.x

Dexamethasone‐resistant Human Pre‐B Leukemia 697 Cell Line Evolving Elevation of Intracellular Glutathione Level: An Additional Resistance Mechanism

Hitoshi Inoue 1, Haruyuki Takemura 1, Yasukazu Kawai 1, Akira Yoshida 1, Takanori Ueda 1,, Toshiyuki Miyashita 2
PMCID: PMC5927028  PMID: 12036455

Abstract

Glucocorticoids remain among the most important drugs in the treatment of acute lymphoblastic leukemia (ALL). Although the mechanisms of glucocorticoid resistance have been studied in some T‐cell leukemic cell lines, less work has been done with B‐cell lines. We established a dexamethasone (DEX)‐resistant human pre‐B lineage leukemia cell line (697/DEX) and investigated the mechanism of resistance. 697/DEX was over 430–fold more resistant to DEX compared with the parental cells (697/Neo). Overexpression of Bcl–2 protein was not observed in 697/DEX, different from the mechanism of resistance in Bcl–2–virus‐infected cells (697/Bcl–2). Although the expression of p‐glycoprotein (Pgp) in 697/DEX was positive, its functional activity was not detected. The numbers of glucocorticoid receptors (GR) in 697/DEX and 697/Bcl–2 were significantly lower than those in 697/Neo. In addition, 697/DEX and 697/Bcl–2 had higher levels of glutathione (GSH) than 697/Neo. In the presence of l‐buthionine‐(S, R)‐sulfoximine (BSO), an inhibitor of GSH synthesis, both 697/DEX and 697/Bcl–2 recovered their sensitivity to DEX. Interestingly, cell death by the depletion of GSH did not involve caspase–3/7 activation in 697/Bcl–2 and 697/DEX, different from 697/Neo, suggesting a death mechanism through caspase‐independent programmed cell death or necrosis. In conclusion, DEX‐resistance in 697/DEX was related not only to a GR decrease, but also to an increase in intracellular GSH level in the DEX‐resistant B‐cell leukemia cell line. Circumvention of DEX‐resistance with BSO may offer an approach to overcoming resistance to chemotherapy in B‐cell lineage ALL.

Keywords: Dexamethasone (DEX), 697 cells, Bcl–2, Glutathione (GSH), Caspase–3

Full Text

The Full Text of this article is available as a PDF (117.6 KB).

REFERENCES

  • 1. ) Kaspers , G. J. , Pieters , R. , Klumper , E. , De Waal , F. and Veerman , A. J.Glucocorticoid resistance in childhood leukemia . Leuk. Lymphoma , 13 , 187 – 201 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Federico , M. H. , Martins , V. R. , Pozzi , D. H. , Llacer , P. E. and Brentani , M. M.Glucocorticoid receptors in acute leukemia . Braz. J. Med. Biol. Res. , 19 , 167 – 172 ( 1986. ). [PubMed] [Google Scholar]
  • 3. ) Ueda , T. , Miyawaki , S. , Asou , N. , Kuraishi , Y. , Hiraoka , A. , Kuriyama , K. , Minami , S. , Ohshima , T. , Ino , T. , Tamura , J. , Kanamaru , A. , Nishikawa , K. , Tanimoto , M. , Oh , H. , Saito , K. , Nagata , K. , Naoe , T. , Yamada , O. , Urasaki , Y. , Sakura , T. and Ohno , R.Response‐oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group . Int. J. Hematol. , 68 , 279 – 289 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Gaynon , P. S. and Carrel , A. L.Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia . Adv. Exp. Med. Biol. , 457 , 593 – 605 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Maung , Z. T. , Reid , M. M. , Matheson , E. , Taylor , P. R. , Proctor , S. J. and Hall , A. G.Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia . Br. J. Haematol. , 91 , 93 – 100 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Dordelmann , M. , Reiter , A. , Borkhardt , A. , Ludwig , W. D. , Gotz , N. , Viehmann , S. , Gadner , H. , Riehm , H. and Schrappe , M.Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia . Blood , 94 , 1209 – 1217 ( 1999. ). [PubMed] [Google Scholar]
  • 7. ) Kaspers , G. J. , Pieters , R. , Van , Z. C. , Van , W. E. , Van , D. D. , Van , D. B. A. and Veerman , A. J.Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro‐vivo correlations and cross‐resistance to other drugs . Blood , 92 , 259 – 266 ( 1998. ). [PubMed] [Google Scholar]
  • 8. ) Kaspers , G. J. , Veerman , A. J. , Pieters , R. , Van , Z. C. , Smets , L. A. , Van , W. E. , Van , D. D. and Van , D. B. A.In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia . Blood , 90 , 2723 – 2729 ( 1997. ). [PubMed] [Google Scholar]
  • 9. ) Moalli , P. A. and Rosen , S. T.Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies . Leuk. Lymphoma , 15 , 363 – 374 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Costlow , M. E. , Pui , C. H. and Dahl , G. V.Glucocorticoid receptors in childhood acute lymphocytic leukemia . Cancer Res. , 42 , 4801 – 4806 ( 1982. ). [PubMed] [Google Scholar]
  • 11. ) van Kalken , C. K. , Broxterman , H. J. , Pinedo , H. M. , Feller , N. , Dekker , H. , Lankelma , J. and Giaccone , G.Cortisol is transported by the multidrug resistance gene product P‐gly‐coprotein . Br. J. Cancer , 67 , 284 – 289 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Dole , M. , Nunez , G. , Merchant , A. K. , Maybaum , J. , Rode , C. K. , Bloch , C. A. and Castle , V. P.Bcl–2 inhibits chemotherapy‐induced apoptosis in neuroblastoma . Cancer Res. , 54 , 3253 – 3259 ( 1994. ). [PubMed] [Google Scholar]
  • 13. ) Alnemri , E. S. , Fernandes , T. F. , Haldar , S. , Croce , C. M. and Litwack , G.Involvement of BCL–2 in glucocorticoid‐induced apoptosis of human pre‐B‐leukemias . Cancer Res. , 52 , 491 – 495 ( 1992. ). [PubMed] [Google Scholar]
  • 14. ) Miyashita , T. and Reed , J. C.Bcl–2 oncoprotein blocks chemotherapy‐induced apoptosis in a human leukemia cell line . Blood , 81 , 151 – 157 ( 1993. ). [PubMed] [Google Scholar]
  • 15. ) Harmon , J. M. and Thompson , E. B.Isolation and characterization of dexamethasone‐resistant mutants from human lymphoid cell line CEM‐C7 . Mol. Cell. Biol. , 6 , 512 – 521 ( 1981. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Geley , S. , Hartmann , B. L. , Hala , M. , Strasser‐Wozak , E. M. , Kapelari , K. and Kofler , R.Resistance to glucocorticoid‐induced apoptosis in human T‐cell acute lymphoblastic leukemia CEM‐C1 cells is due to insufficient glucocorticoid receptor expression . Cancer Res. , 56 , 5033 – 5038 ( 1996. ). [PubMed] [Google Scholar]
  • 17. ) Maung , Z. T. , Hogarth , L. , Reid , M. M. , Proctor , S. J. , Hamilton , P. J. and Hall , A. G.Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukaemia . Leukemia , 8 , 1487 – 1491 ( 1994. ). [PubMed] [Google Scholar]
  • 18. ) Kearns , P. , Pieters , R. , Rottier , M. M. A. , Veerman , A. J. P. , Schmiegalow , K. , Pearson , A. D. J. and Hall , A. G.Glutathione in childhood acute leukaemias . Adv. Exp. Med. Biol. , 457 , 211 – 216 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Aiello , A. , Delia , D. , Borrello , M. G. , Biassoni , D. , Giardini , R. , Fontanella , E. , Pezzella , F. , Pulford , K. , Pierotti , M. and Delia , P. G.Flow cytometric detection of the mitochondrial BCL–2 protein in normal and neoplastic human lymphoid cells . Cytometry , 13 , 502 – 509 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Tosi , P. , Visani , G. , Ottaviani , E. , Manfroi , S. and Tura , S.Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia . Eur. J. Haematol. , 57 , 134 – 141 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Chaudhary , P. M. , Mechetner , E. B. and Roninson , I. B.Expression and activity of the multidrug resistance P‐glyco‐protein in human peripheral blood lymphocytes . Blood , 80 , 2735 – 2739 ( 1992. ). [PubMed] [Google Scholar]
  • 22. ) Flens , M. J. , Izquierdo , M. A. , Scheffer , G. L. , Fritz , J. M. , Meijer , C. J. , Scheper , R. J. and Zaman , G. J.Immunochemical detection of the multidrug resistance‐associated protein MRP in human multidrug‐resistant tumor cells by monoclonal antibodies . Cancer Res. , 54 , 4557 – 4563 ( 1994. ). [PubMed] [Google Scholar]
  • 23. ) Webb , M. , Raphael , C. L. , Asbahr , H. , Erber , W. N. and Meyer , B. F.The detection of rhodamine 123 efflux at low levels of drug resistance . Br. J. Haematol. , 93 , 650 – 655 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Takemura , H. , Urasaki , Y. , Yoshida , A. , Fukushima , T. and Ueda , T.Simultaneous treatment with 1‐β‐d‐arabinofura‐nosylcytosine and daunorubicin induces cross‐resistance to both drugs due to a combination‐specific mechanism in HL60 cells . Cancer Res. , 61 , 172 – 177 ( 2001. ). [PubMed] [Google Scholar]
  • 25. ) Feller , N. , Broxterman , H. J. , Wahrer , D. C. and Pinedo , H. M.ATP‐dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion . FEBS Lett. , 368 , 385 – 388 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Smets , L. A. , van der Klooster , P. and Otte , A.Glucocorticoid receptors of normal and leukemic cells: role of proliferation conditions . Leuk. Res. , 9 , 199 – 207 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Scatchard , G.Attraction of proteins for small molecules and ions . Ann. NY Acad. Sci. , 51 , 660 – 672 ( 1949. ). [Google Scholar]
  • 28. ) Tietze , F.Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues . Anal. Biochem. , 27 , 502 – 522 ( 1969. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Lai , G. M. , Moscow , J. A. , Alvarez , M. G. , Fojo , A. T. and Bates , S. E.Contribution of glutathione and glutathione‐dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines . Int. J. Cancer , 49 , 688 – 695 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Dimmeler , S. , Haendeler , J. , Nehls , M. and Zeiher , A. M.Suppression of apoptosis by nitric oxide via inhibition of interleukin–1beta‐converting enzyme (ICE)‐like and cysteine protease protein (CPP)–32–like proteases . J. Exp. Med. , 185 , 601 – 607 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. ) Smets , L. A. , Van den Berg , J. , Acton , D. , Top , B. , Van , R. H. and Verwijs , J. M.BCL–2 expression and mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid‐induced apoptosis . Blood , 84 , 1613 – 1619 ( 1994. ). [PubMed] [Google Scholar]
  • 32. ) Aszalos , A. and Ross , D. D.Biochemical and clinical aspects of efflux pump related resistance to anti‐cancer drugs . Anticancer Res. , 18 , 2937 – 2944 ( 1998. ). [PubMed] [Google Scholar]
  • 33. ) Pallis , M. and Russell , N.P‐glycoprotein plays a drug‐efflux‐independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin‐ceramide apoptotic pathway . Blood , 95 , 2897 – 2904 ( 2000. ). [PubMed] [Google Scholar]
  • 34. ) Nicklas , B. E. , Rosemary , B. E. and John , A. C.In vivo resistance to glucocorticoid‐induced apoptosis in rat thymocytes with normal steroid receptor function in vitro . Endocrinology , 138 , 810 – 818 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Miyashita , T. and Reed , J. C.bcl–2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs . Cancer Res. , 52 , 5407 – 5411 ( 1992. ). [PubMed] [Google Scholar]
  • 36. ) Leek , R. D. , Kaklamanis , L. , Pezzella , F. , Gatter , K. C. and Harris , A. L.bcl–2 in normal human breast and carcinoma, association with oestrogen receptor‐positive, epidermal growth factor receptor‐negative tumours and in situ cancer . Br. J. Cancer , 69 , 135 – 139 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. ) Zhang , K. , Mack , P. and Wong , K. P.Glutathione‐related mechanisms in cellular resistance to anticancer drugs . Int. J. Oncol. , 12 , 871 – 882 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 38. ) Iwata , S. , Hori , T. , Sato , N. , Hirota , K. , Sasada , T. , Mitsui , A. , Hirakawa , T. and Yodoi , J.Adult T cell leukemia (ATL)‐derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by l‐cystine and glutathione depletion: possible involvement of thiol‐mediated redox regulation in apoptosis caused by pro‐oxidant state . J. Immunol. , 158 , 3108 – 3117 ( 1997. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES